Our overall aim is to elucidate the early cytogenetic and molecular genetic events underlining estrogen-induced renal tumorigenesis in the hamster kidney and compare these findings to the hamster renal tumor and to our two """"""""semi-immortal"""""""" estrogen-derived kidney cell lines. The strength of this application resides in the experience of two well established groups working with hamster systems with complementary abilities. The collaborating group will develop a battery of expression tagged sites (ETS) to established a physical map of the hamster genome, and eventually a genetic map which will be used to identify the affected genes being altered during renal tumorigenesis. To pursued these aims, the following studies are proposed: 1. Systematic cytogenetic analyses of the kidney tumor and kidney during estrogen-induced tumorigenesis. This will be done by detail studies of the temporal relationship of various cytogenetic alterations during renal tumorigenesis. Nonrandom chromosome alterations (gains and losses) will be determined at monthly intervals of estrogen treatment, they will be related to nonrandom numerical changes, and the frequency and location of fragile sites will be determined on hamster kidney chromosomes in estrogenized kidneys, renal tumor, and DES-derived kidney cell lines. 2. Screen for cDNA probes for protooncogene and other pertinent receptor protein expression during estrogen-induced tumorigenesis. This will be done by hybridization of newly synthesized RNA from hamster kidneys at different stages of estrogen treatment to an array of cDNA clones. The clones that will exhibit changed expression will be confirmed by Northern hybridization. These studies will complement Specific Aims 1 and 4. The study of cellular expression of the cDNA probes will be a prelude to in-situ hybridization studies both on the chromosome and within estrogenized kidney and tumor cells. 3. Create a battery of expression tagged sites (ETS) to establish a physical map of the Syrian hamster genome. Hamsters will be mapped with probes from a random sample of transcription units. A hamster genetic map will be established and will then be used as a road map to identify genes involved in the carcinogenic process. cDNA clones will be isolated, and 150-300 bp regions sequenced from both ends. Sequence information will be used to search the genome database. 4. Establish a genetic map with ETS and other relevant loci. Develop syntenic groups. This will be done by in situ hybridization of hamster metaphase spreads. Syntenic groups will be generated by comparison analysis of hamster data to the mouse and human genome database.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA058030-04
Application #
2098745
Study Section
Special Emphasis Panel (SRC (68))
Project Start
1992-08-07
Project End
1997-05-31
Budget Start
1995-06-01
Budget End
1996-05-31
Support Year
4
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Kansas
Department
Pharmacology
Type
Schools of Medicine
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Weroha, S John; Li, Sara Antonia; Tawfik, Ossama et al. (2006) Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats. Carcinogenesis 27:491-8
Li, Jonathan J; Li, Sara Antonia (2003) Causation and prevention of solely estrogen-induced oncogenesis: similarities to human ductal breast cancer. Adv Exp Med Biol 532:195-207
Li, S A; Weroha, S J; Tawfik, O et al. (2002) Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: evidence for estrogen receptor mediation. J Endocrinol 175:297-305
Li, Jonathan J; Papa, Dan; Davis, Marilyn F et al. (2002) Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: comparison to invasive human ductal breast cancer. Mol Carcinog 33:56-65
Mesia-Vela, Sonia; Sanchez, Rosa I; Li, Jonathan J et al. (2002) Catechol estrogen formation in liver microsomes from female ACI and Sprague-Dawley rats: comparison of 2- and 4-hydroxylation revisited. Carcinogenesis 23:1369-72
Li, J J; Weroha, S J; Davis, M F et al. (2001) ER and PR in renomedullary interstitial cells during Syrian hamster estrogen-induced tumorigenesis: evidence for receptor-mediated oncogenesis. Endocrinology 142:4006-14
Liao, D Z; Hou, X; Bai, S et al. (2000) Unusual deregulation of cell cycle components in early and frank estrogen-induced renal neoplasias in the Syrian hamster. Carcinogenesis 21:2167-73
Li, J J; Hou, X; Banerjee, S K et al. (1999) Overexpression and amplification of c-myc in the Syrian hamster kidney during estrogen carcinogenesis: a probable critical role in neoplastic transformation. Cancer Res 59:2340-6
Li, J J; Hou, X; Bentel, J et al. (1998) Prevention of estrogen carcinogenesis in the hamster kidney by ethinylestradiol: some unique properties of a synthetic estrogen. Carcinogenesis 19:471-7
Li, S A; Liao, D Z; Yazlovitskaya, E M et al. (1997) Induction of cathepsin D protein during estrogen carcinogenesis: possible role in estrogen-mediated kidney tubular cell damage. Carcinogenesis 18:1375-80

Showing the most recent 10 out of 14 publications